Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrazones | 1 | 2024 | 19 | 0.920 |
Why?
|
| Pyridazines | 1 | 2024 | 49 | 0.900 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2024 | 102 | 0.870 |
Why?
|
| Cardiotonic Agents | 1 | 2024 | 135 | 0.840 |
Why?
|
| Fibroblasts | 2 | 2024 | 880 | 0.700 |
Why?
|
| Myocardium | 1 | 2024 | 985 | 0.640 |
Why?
|
| Oxidative Stress | 1 | 2024 | 795 | 0.640 |
Why?
|
| Immunoglobulin E | 7 | 2003 | 159 | 0.500 |
Why?
|
| Allergens | 7 | 2003 | 245 | 0.450 |
Why?
|
| Signal Transduction | 2 | 2024 | 4490 | 0.400 |
Why?
|
| Plant Proteins | 5 | 2003 | 74 | 0.320 |
Why?
|
| Hypersensitivity | 3 | 2003 | 182 | 0.250 |
Why?
|
| Heart Failure, Diastolic | 1 | 2024 | 11 | 0.230 |
Why?
|
| Heme Oxygenase-1 | 1 | 2024 | 34 | 0.230 |
Why?
|
| Diastole | 1 | 2024 | 169 | 0.220 |
Why?
|
| Skin Tests | 3 | 2003 | 73 | 0.220 |
Why?
|
| Fibrosis | 1 | 2024 | 429 | 0.200 |
Why?
|
| Transcriptional Activation | 1 | 2024 | 481 | 0.200 |
Why?
|
| Cell Survival | 1 | 2024 | 808 | 0.200 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2024 | 359 | 0.180 |
Why?
|
| Receptors, Progesterone | 2 | 2005 | 866 | 0.180 |
Why?
|
| Antigens, Dermatophagoides | 3 | 2003 | 9 | 0.160 |
Why?
|
| Rats | 1 | 2024 | 3653 | 0.150 |
Why?
|
| Apoptosis | 1 | 2024 | 1781 | 0.140 |
Why?
|
| Antigen-Antibody Reactions | 2 | 2002 | 59 | 0.120 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2004 | 21 | 0.120 |
Why?
|
| Antigens, Plant | 5 | 2003 | 32 | 0.120 |
Why?
|
| Serine | 1 | 2004 | 172 | 0.110 |
Why?
|
| Immunoglobulin Isotypes | 2 | 2002 | 15 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2005 | 315 | 0.110 |
Why?
|
| Immunoglobulin G | 3 | 2002 | 769 | 0.110 |
Why?
|
| Transcription, Genetic | 2 | 2005 | 1702 | 0.100 |
Why?
|
| Glycoproteins | 2 | 2002 | 369 | 0.100 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 298 | 0.090 |
Why?
|
| Hypersensitivity, Immediate | 1 | 1999 | 16 | 0.080 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1999 | 47 | 0.080 |
Why?
|
| Mice | 2 | 2024 | 17541 | 0.080 |
Why?
|
| Asthma | 2 | 2003 | 742 | 0.080 |
Why?
|
| Immunotherapy | 2 | 2000 | 662 | 0.070 |
Why?
|
| Antibody Affinity | 3 | 2002 | 39 | 0.070 |
Why?
|
| Animals | 3 | 2024 | 33794 | 0.070 |
Why?
|
| Breast Neoplasms | 2 | 2005 | 2479 | 0.060 |
Why?
|
| Antibody Specificity | 3 | 2002 | 202 | 0.060 |
Why?
|
| Progestins | 2 | 2005 | 48 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 1691 | 0.060 |
Why?
|
| Humans | 10 | 2024 | 123092 | 0.050 |
Why?
|
| Binding, Competitive | 2 | 2002 | 180 | 0.050 |
Why?
|
| Asteraceae | 2 | 2000 | 2 | 0.040 |
Why?
|
| Pollen | 2 | 2000 | 45 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2005 | 3292 | 0.040 |
Why?
|
| Mitogens | 1 | 2004 | 30 | 0.030 |
Why?
|
| Cyclin E | 1 | 2004 | 30 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 94 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2005 | 111 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2004 | 49 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2004 | 58 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 111 | 0.030 |
Why?
|
| Adult | 5 | 2003 | 29018 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 198 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2005 | 312 | 0.030 |
Why?
|
| Adolescent | 4 | 2003 | 19104 | 0.030 |
Why?
|
| Alanine | 1 | 2004 | 181 | 0.030 |
Why?
|
| Mites | 1 | 2003 | 5 | 0.030 |
Why?
|
| Arthropod Proteins | 1 | 2003 | 11 | 0.030 |
Why?
|
| Ambrosia | 1 | 2003 | 14 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2004 | 408 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 389 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2004 | 617 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 2003 | 114 | 0.030 |
Why?
|
| Ligands | 1 | 2004 | 530 | 0.030 |
Why?
|
| Patch Tests | 1 | 2003 | 6 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2003 | 74 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2003 | 169 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2004 | 809 | 0.030 |
Why?
|
| RNA Interference | 1 | 2004 | 496 | 0.030 |
Why?
|
| Middle Aged | 4 | 2003 | 25993 | 0.030 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2002 | 29 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2005 | 803 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 452 | 0.030 |
Why?
|
| Dermatitis, Atopic | 1 | 2003 | 41 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2005 | 675 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2005 | 614 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2004 | 1100 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2004 | 697 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2003 | 6369 | 0.020 |
Why?
|
| Differential Threshold | 1 | 2002 | 11 | 0.020 |
Why?
|
| Child | 4 | 2003 | 24231 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2003 | 294 | 0.020 |
Why?
|
| Binding Sites, Antibody | 1 | 2002 | 98 | 0.020 |
Why?
|
| Age Distribution | 1 | 2003 | 409 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2002 | 174 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 467 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2004 | 793 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2004 | 1608 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 644 | 0.020 |
Why?
|
| Aged | 3 | 2003 | 19092 | 0.020 |
Why?
|
| Immunodominant Epitopes | 1 | 2000 | 50 | 0.020 |
Why?
|
| Models, Biological | 1 | 2005 | 1444 | 0.020 |
Why?
|
| Cell Line | 1 | 2005 | 2771 | 0.020 |
Why?
|
| Family | 1 | 2003 | 570 | 0.020 |
Why?
|
| Male | 5 | 2003 | 60091 | 0.020 |
Why?
|
| Genes, Immunoglobulin | 1 | 1999 | 33 | 0.020 |
Why?
|
| Rhinitis | 1 | 1999 | 38 | 0.020 |
Why?
|
| Immunoassay | 1 | 1999 | 124 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2004 | 3042 | 0.020 |
Why?
|
| Female | 5 | 2003 | 65538 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1999 | 192 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2005 | 2307 | 0.020 |
Why?
|
| Age Factors | 1 | 2003 | 2803 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2000 | 2696 | 0.020 |
Why?
|
| Incidence | 1 | 2003 | 3043 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2000 | 3868 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 2846 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2003 | 3316 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2003 | 4703 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1999 | 2526 | 0.010 |
Why?
|